Trademark/Service Mark Application, Principal Register
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Dikean Management AG
INTERNAL ADDRESS
c/o Therachon AG
*STREET
Aeschenvorstadt 36
*CITY
Basel
*COUNTRY
Switzerland
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
4051
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY OF INCORPORATION
Switzerland
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
001
*IDENTIFICATION
Active plant agents and plant extracts for research purposes
FILING BASIS
SECTION 1(b)
FILING BASIS
SECTION 44(d)
FOREIGN APPLICATION NUMBER
07882/2019
FOREIGN APPLICATION
COUNTRY
Switzerland
FOREIGN FILING DATE
06/11/2019
INTENT TO
PERFECT 44(d)
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the
submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
INTERNATIONAL CLASS
005
*IDENTIFICATION
Nutritional additives for medical purposes in the nature of natural food extracts derived from herbs, fruits, spices, vegetables, algae, fungi
or in the nature of minerals, trace-elements, vitamins, micronutrients; a full line of medicines, particularly phytopharmaceuticals; active plant agents and plant extracts for medical use; a full
line of pharmaceutical and veterinary preparations for the treatment of human and animal diseases; sanitary preparations for medical use; dietetic food, namely, herbs, fruits, spices, vegetables,
algae, fungi or in the nature of minerals, trace-elements, vitamins, micro-nutrients adapted for medical use, food for babies; adjuvants for medical purposes; amino acids for medical purposes;
anaesthetics; analgesics; vermifuges; antibiotics; a full line of biological preparations for the treatment of human and animal diseases; chemical active components for medical use, namely, chemical
preparations for treating genetic conditions, rare diseases and conditions; chemical reagents for medical or veterinary purposes; a full line of chemico-pharmaceutical preparations for the treatment
of human and animal diseases; a full line of ferments for pharmaceutical purposes; hormones for medical purposes; a full line of medical infusions for the treatment of human and animal diseases;
medicines for the treatment of gum disease, caries, toothache or wound healing of the gums; a full line of medicines for the treatment of human diseases; radiological contrast substances for medical
purposes; steroids
FILING BASIS
SECTION 1(b)
FILING BASIS
SECTION 44(d)
FOREIGN APPLICATION NUMBER
07882/2019
FOREIGN APPLICATION
COUNTRY
Switzerland
FOREIGN FILING DATE
06/11/2019
INTENT TO
PERFECT 44(d)
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the
submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
INTERNATIONAL CLASS
010
*IDENTIFICATION
Surgical, medical, dental and veterinary apparatus and instruments; apparatus, devices and instruments for treating genetic conditions, rare
diseases and conditions; artificial limbs, eyes and teeth; orthopaedic articles; suture materials; therapeutic and assistive devices adapted for the disabled; massage apparatus; apparatus, devices
and articles for nursing infants; sexual activity apparatus, devices and articles
FILING BASIS
SECTION 1(b)
FILING BASIS
SECTION 44(d)
FOREIGN APPLICATION NUMBER
07882/2019
FOREIGN APPLICATION
COUNTRY
Switzerland
FOREIGN FILING DATE
06/11/2019
INTENT TO
PERFECT 44(d)
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the
submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
INTERNATIONAL CLASS
042
*IDENTIFICATION
Scientific research, technological development of new products for others; medical research; scientific and industrial research in the field
of biotechnology, biology, rare diseases and conditions, genetic conditions and/or treatments of rare diseases and conditions; industrial research in the field of biomedical and phytopharmaceutical
engineering; services of a pharmaceutical laboratory; pharmaceutical research and development; scientific services, namely, development of drugs, active agents and vaccines; scientific services,
namely, development of food supplements; development and preparation of pharmaceutical preparations and medicines and plant extracts for use in pharmaceutical preparations and medicines
FILING BASIS
SECTION 1(b)
FILING BASIS
SECTION 44(d)
FOREIGN APPLICATION NUMBER
07882/2019
FOREIGN APPLICATION
COUNTRY
Switzerland
FOREIGN FILING DATE
06/11/2019
INTENT TO
PERFECT 44(d)
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the
submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
INTERNATIONAL CLASS
044
*IDENTIFICATION
Consulting on medicines
FILING BASIS
SECTION 1(b)
FILING BASIS
SECTION 44(d)
FOREIGN APPLICATION NUMBER
07882/2019
FOREIGN APPLICATION
COUNTRY
Switzerland
FOREIGN FILING DATE
06/11/2019
INTENT TO
PERFECT 44(d)
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the
submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
ATTORNEY INFORMATION
NAME
Stacey Halpern
ATTORNEY DOCKET NUMBER
EBLM057.001T
FIRM NAME
Knobbe, Martens, Olson & Bear, LLP
STREET
2040 Main Street, 14th Floor
CITY
Irvine
STATE
California
COUNTRY
United States
ZIP/POSTAL CODE
92614
PHONE
949-760-0404
FAX
949-760-9502
EMAIL ADDRESS
efiling@knobbe.com
AUTHORIZED TO COMMUNICATE VIA EMAIL
Yes
OTHER APPOINTED ATTORNEY
John B. Sganga, Jr., Edward A. Schlatter, Gerard von Hoffmann, Joseph R. Re, Catherine J. Holland, John M. Carson, Karen Vogel Weil, Jeffrey
L. Van Hoosear, Daniel E. Altman, Lynda J. Zadra-Symes, William H. Shreve, Stephen C. Jensen, Steven J. Nataupsky, Paul A. Stewart, Joseph F. Jennings, Craig S. Summers, Diane M. Reed, Ronald J.
Schoenbaum, John R. King, Adeel S. Akhtar, David N. Weiss, Douglas G. Muehlhauser, Lori Lee Yamato, Michael K. Friedland, Stacey R. Halpern, Mark M. Abumeri, Jon W. Gurka, Joseph M. Reisman, Michael
L. Fuller, Mark R. Benedict, Paul N. Conover, Robert J. Roby, Sabing H. Lee, Karoline A. Delaney, Joseph S. Cianfrani, William R. Zimmerman, Eric S. Furman, Susan M. Natland, Rose M. Thiessen,
Michael A. Guiliana, Rabinder N. Narula, Bruce S. Itchkawitz, John M. Grover, Irfan A. Lateef, Amy Christensen Chun, Mark J. Gallagher, David G. Jankowski, Brian C. Horne, Payson LeMeilleur, Sheila
N. Swaroop, Benjamin A. Katzenellenbogen, Andrew N. Merickel, Thomas P. Krzeminski, Linda H. Liu, James F. Herkenhoff, Andrew M. Douglas, Salima A. Merani, Jonathan A. Hyman, Curtiss C. Dosier,
Joseph J. Mallon, Sean M. Murray, Christy G. Lea, Perry D. Oldham, Russell M. Jeide, Zi Y. Wong, Matthew S. Bellinger, Mincheol Kim, Gregory A. Hermanson, Lauren Keller Katzenellenbogen, Ted M.
Cannon, Carol Pitzel Cruz, Josué A. Villalta, Andrew I. Kimmel, Brenden Gingrich, Maria Culic Anderson, Melanie J. Seelig, Mauricio A. Uribe, Curtis R. Huffmire, Christopher L. Ross, Eli A. Loots,
Ryan E. Melnick, Yanna S. Bouris, Philip M. Nelson, Marko R. Zoretic, Kerry S. Taylor, Derek C. Dailey, Jarom D. Kesler, Steven P. Ruden, Colin B. Heideman, Theodore G. Papagiannis, Nicholas M.
Zovko, Adam J. Gilbert, Kimberly J. Miller, Bryan W. Wahl, Thomas Y. Yee, Agnes Juang, Jason J. Jardine, Jared C. Bunker, Lance D. Smemoe, Joshua J. Stowell, Jonathan E. Bachand, Ali S. Razai, Terry
K. Tullis, Derek R. Bayles, Cheryl T. Burgess, Gregory B. Phillips, Brian C. Claassen, Mark Lezama, Sean Ambrosius, Stephen W. Larson, John L. Paik, Bridget O'L. Smith, Michael R. Christensen,
Benjamin J. Everton, Jason A. Gersting, Baraa Kahf, Alan G. Laquer, Vlad Teplitskiy, Jeffery L. Hallstrom, Maria V. Stout, William O. Adams, Ian W. Gillies, Andrew W. Lloyd, Mark D. Kachner, Lincoln
S. Essig, David R. Trossen, Aaron M. Davis, Jason R. Swartz, Benjamin B. Anger, Jason A. Champion, Daniel V. Gibson, Jeremy J. Carney, Karen M. Cassidy, Adam B. Powell, Karen J. Lenker, Bryan G.
McWhorter, Nathanael R. Luman, Andrea L. Cheek, Damien J. Howard, Jane Q. Dai, Shannon Lam, Peter Law, Mark Metzke, Scott G. Siera, Jacob Peterson, Christie R.W. Matthaei, Vladimir S. Lozan, Paul S.
Stellman, Heungsoo Choi, Nicole Rossi Townes, Vikas Bhargava, Daniel J. Fischer, Jeremy A. Anapol, Scott A. Cromar, Kendall M. Loebbaka, David R. Schmidt, Harnik Shukla, Charlene A. Azema, Morgan R.
Coates, Jessica L. Achtsam, Jonathan A. Menkes, Rosaleen H. Chou, Deborah S. Shepherd, Mark D. Marsden, Joan Y. Chan, Loni L. Morrow, Kyu S. Min, Chang Sik Lim, Thomas S.H. Cowan, Devanie A. DuFour,
Alexander J. Martinez, Hans L. Mayer, Jessica C. Sganga, Nicholas A. Belair, Ryan S. Furtado, Angela K. Dremann, Justin J. Gillett, M. Scott Forbes, Brian M. Graham, Brian J. Flynn, Mitchell B.
Hadley, Qi Peter Tong, Elenore Niu, Michael P. Burns, David M. Cohen, Mark E. Davis, Jordan Gottdank, Kim A. Kennedy, Daniel C. Kiang, Keith M. Lim, Ashley C. Morales, Nathan D. Reeves, Brandon G.
Smith, Xiaoyan Sabrina Wang, Zach Jun Hyuk Hong, Jordan M. Cox, Albert J. Sueiras, Mark Rubinshtein, David J. Grant, Clayton R. Henson, Daniel A. Kamkar, Lesley Y. Kim, Nathan J. Lee, Josepher Li,
Jacob R. Rosenbaum, James F. Smith, Douglas B. Wentzel, Aryeh N. Feinstein, Noorean I. Gill, Peter A. Hecker, Aaron S. Johnson, Bryan J. Johnson, Chanell Khosrowabadi, Lindsay A. Laddaran, Forrest M.
McClellen, Janet M. Allendorph, Alexander Zeng, Sean S. Kim, Benjamin Ho, Adam R. Aquino, Samuel I. Cockriel, Serah R. Friedman, Bita Kianian, Yinan Lin, Eric R. Malmgren, Brian M.Z. Reece, Derk A.
Westermeyer, Suyoung Jang, Show Xiaoyu Wang, Justin E. Culbertson, Andrew E. Morrell, Victoria E. Ellis, Yasmin L. Amin-Reimer, Jeremiah S. Helm, Hironori Kubota, Paul C. Steinhardt, Kregg A. Koch,
Andrew D. Lee, and Yusuke Hirai
DOMESTIC REPRESENTATIVE INFORMATION
NAME
Stacey Halpern
FIRM NAME
Knobbe, Martens, Olson & Bear, LLP
STREET
2040 Main Street, 14th Floor
CITY
Irvine
STATE
California
COUNTRY
United States
ZIP CODE
92614
PHONE
949-760-0404
FAX
949-760-9502
EMAIL ADDRESS
efiling@knobbe.com
AUTHORIZED TO COMMUNICATE VIA EMAIL
Yes
CORRESPONDENCE INFORMATION
NAME
Stacey Halpern
FIRM NAME
Knobbe, Martens, Olson & Bear, LLP
STREET
2040 Main Street, 14th Floor
CITY
Irvine
STATE
California
COUNTRY
United States
ZIP/POSTAL CODE
92614
PHONE
949-760-0404
FAX
949-760-9502
*EMAIL ADDRESS
efiling@knobbe.com
*AUTHORIZED TO COMMUNICATE VIA EMAIL
Yes
FEE INFORMATION
APPLICATION FILING OPTION
TEAS RF
NUMBER OF CLASSES
5
APPLICATION FOR REGISTRATION PER CLASS
275
*TOTAL FEE DUE
1375
*TOTAL FEE PAID
1375
SIGNATURE INFORMATION
SIGNATURE
NOT PROVIDED
SIGNATORY'S NAME
NOT PROVIDED
SIGNATORY'S POSITION
NOT PROVIDED
DATE SIGNED
NOT PROVIDED
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
Serial Number:88468906
Filing Date:06/11/2019
To the Commissioner for Trademarks:
MARK: VECTIVBIO (Standard Characters, see mark)
The literal element of the mark consists of VECTIVBIO.
The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Dikean Management AG, a corporation of Switzerland, having an address of
c/o Therachon AG
Aeschenvorstadt 36
Basel 4051
Switzerland
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 001: Active plant agents and plant extracts for research purposes
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of
priority based on Switzerland application number 07882/2019, filed 06/11/2019.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the
foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
International Class 005: Nutritional additives for medical purposes in the nature of natural food extracts derived from herbs, fruits, spices, vegetables,
algae, fungi or in the nature of minerals, trace-elements, vitamins, micronutrients; a full line of medicines, particularly phytopharmaceuticals; active plant agents and plant extracts for medical
use; a full line of pharmaceutical and veterinary preparations for the treatment of human and animal diseases; sanitary preparations for medical use; dietetic food, namely, herbs, fruits, spices,
vegetables, algae, fungi or in the nature of minerals, trace-elements, vitamins, micro-nutrients adapted for medical use, food for babies; adjuvants for medical purposes; amino acids for medical
purposes; anaesthetics; analgesics; vermifuges; antibiotics; a full line of biological preparations for the treatment of human and animal diseases; chemical active components for medical use, namely,
chemical preparations for treating genetic conditions, rare diseases and conditions; chemical reagents for medical or veterinary purposes; a full line of chemico-pharmaceutical preparations for the
treatment of human and animal diseases; a full line of ferments for pharmaceutical purposes; hormones for medical purposes; a full line of medical infusions for the treatment of human and animal
diseases; medicines for the treatment of gum disease, caries, toothache or wound healing of the gums; a full line of medicines for the treatment of human diseases; radiological contrast substances
for medical purposes; steroids
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of
priority based on Switzerland application number 07882/2019, filed 06/11/2019.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the
foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
International Class 010: Surgical, medical, dental and veterinary apparatus and instruments; apparatus, devices and instruments for treating genetic
conditions, rare diseases and conditions; artificial limbs, eyes and teeth; orthopaedic articles; suture materials; therapeutic and assistive devices adapted for the disabled; massage apparatus;
apparatus, devices and articles for nursing infants; sexual activity apparatus, devices and articles
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of
priority based on Switzerland application number 07882/2019, filed 06/11/2019.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the
foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
International Class 042: Scientific research, technological development of new products for others; medical research; scientific and industrial research in
the field of biotechnology, biology, rare diseases and conditions, genetic conditions and/or treatments of rare diseases and conditions; industrial research in the field of biomedical and
phytopharmaceutical engineering; services of a pharmaceutical laboratory; pharmaceutical research and development; scientific services, namely, development of drugs, active agents and vaccines;
scientific services, namely, development of food supplements; development and preparation of pharmaceutical preparations and medicines and plant extracts for use in pharmaceutical preparations and
medicines
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of
priority based on Switzerland application number 07882/2019, filed 06/11/2019.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the
foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
International Class 044: Consulting on medicines
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of
priority based on Switzerland application number 07882/2019, filed 06/11/2019.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the
foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
The applicant's current Attorney Information:
Stacey Halpern and John B. Sganga, Jr., Edward A. Schlatter, Gerard von Hoffmann, Joseph R. Re, Catherine J. Holland, John M. Carson, Karen Vogel Weil, Jeffrey L.
Van Hoosear, Daniel E. Altman, Lynda J. Zadra-Symes, William H. Shreve, Stephen C. Jensen, Steven J. Nataupsky, Paul A. Stewart, Joseph F. Jennings, Craig S. Summers, Diane M. Reed, Ronald J.
Schoenbaum, John R. King, Adeel S. Akhtar, David N. Weiss, Douglas G. Muehlhauser, Lori Lee Yamato, Michael K. Friedland, Stacey R. Halpern, Mark M. Abumeri, Jon W. Gurka, Joseph M. Reisman, Michael
L. Fuller, Mark R. Benedict, Paul N. Conover, Robert J. Roby, Sabing H. Lee, Karoline A. Delaney, Joseph S. Cianfrani, William R. Zimmerman, Eric S. Furman, Susan M. Natland, Rose M. Thiessen,
Michael A. Guiliana, Rabinder N. Narula, Bruce S. Itchkawitz, John M. Grover, Irfan A. Lateef, Amy Christensen Chun, Mark J. Gallagher, David G. Jankowski, Brian C. Horne, Payson LeMeilleur, Sheila
N. Swaroop, Benjamin A. Katzenellenbogen, Andrew N. Merickel, Thomas P. Krzeminski, Linda H. Liu, James F. Herkenhoff, Andrew M. Douglas, Salima A. Merani, Jonathan A. Hyman, Curtiss C. Dosier,
Joseph J. Mallon, Sean M. Murray, Christy G. Lea, Perry D. Oldham, Russell M. Jeide, Zi Y. Wong, Matthew S. Bellinger, Mincheol Kim, Gregory A. Hermanson, Lauren Keller Katzenellenbogen, Ted M.
Cannon, Carol Pitzel Cruz, Josué A. Villalta, Andrew I. Kimmel, Brenden Gingrich, Maria Culic Anderson, Melanie J. Seelig, Mauricio A. Uribe, Curtis R. Huffmire, Christopher L. Ross, Eli A. Loots,
Ryan E. Melnick, Yanna S. Bouris, Philip M. Nelson, Marko R. Zoretic, Kerry S. Taylor, Derek C. Dailey, Jarom D. Kesler, Steven P. Ruden, Colin B. Heideman, Theodore G. Papagiannis, Nicholas M.
Zovko, Adam J. Gilbert, Kimberly J. Miller, Bryan W. Wahl, Thomas Y. Yee, Agnes Juang, Jason J. Jardine, Jared C. Bunker, Lance D. Smemoe, Joshua J. Stowell, Jonathan E. Bachand, Ali S. Razai, Terry
K. Tullis, Derek R. Bayles, Cheryl T. Burgess, Gregory B. Phillips, Brian C. Claassen, Mark Lezama, Sean Ambrosius, Stephen W. Larson, John L. Paik, Bridget O'L. Smith, Michael R. Christensen,
Benjamin J. Everton, Jason A. Gersting, Baraa Kahf, Alan G. Laquer, Vlad Teplitskiy, Jeffery L. Hallstrom, Maria V. Stout, William O. Adams, Ian W. Gillies, Andrew W. Lloyd, Mark D. Kachner, Lincoln
S. Essig, David R. Trossen, Aaron M. Davis, Jason R. Swartz, Benjamin B. Anger, Jason A. Champion, Daniel V. Gibson, Jeremy J. Carney, Karen M. Cassidy, Adam B. Powell, Karen J. Lenker, Bryan G.
McWhorter, Nathanael R. Luman, Andrea L. Cheek, Damien J. Howard, Jane Q. Dai, Shannon Lam, Peter Law, Mark Metzke, Scott G. Siera, Jacob Peterson, Christie R.W. Matthaei, Vladimir S. Lozan, Paul S.
Stellman, Heungsoo Choi, Nicole Rossi Townes, Vikas Bhargava, Daniel J. Fischer, Jeremy A. Anapol, Scott A. Cromar, Kendall M. Loebbaka, David R. Schmidt, Harnik Shukla, Charlene A. Azema, Morgan R.
Coates, Jessica L. Achtsam, Jonathan A. Menkes, Rosaleen H. Chou, Deborah S. Shepherd, Mark D. Marsden, Joan Y. Chan, Loni L. Morrow, Kyu S. Min, Chang Sik Lim, Thomas S.H. Cowan, Devanie A. DuFour,
Alexander J. Martinez, Hans L. Mayer, Jessica C. Sganga, Nicholas A. Belair, Ryan S. Furtado, Angela K. Dremann, Justin J. Gillett, M. Scott Forbes, Brian M. Graham, Brian J. Flynn, Mitchell B.
Hadley, Qi Peter Tong, Elenore Niu, Michael P. Burns, David M. Cohen, Mark E. Davis, Jordan Gottdank, Kim A. Kennedy, Daniel C. Kiang, Keith M. Lim, Ashley C. Morales, Nathan D. Reeves, Brandon G.
Smith, Xiaoyan Sabrina Wang, Zach Jun Hyuk Hong, Jordan M. Cox, Albert J. Sueiras, Mark Rubinshtein, David J. Grant, Clayton R. Henson, Daniel A. Kamkar, Lesley Y. Kim, Nathan J. Lee, Josepher Li,
Jacob R. Rosenbaum, James F. Smith, Douglas B. Wentzel, Aryeh N. Feinstein, Noorean I. Gill, Peter A. Hecker, Aaron S. Johnson, Bryan J. Johnson, Chanell Khosrowabadi, Lindsay A. Laddaran, Forrest M.
McClellen, Janet M. Allendorph, Alexander Zeng, Sean S. Kim, Benjamin Ho, Adam R. Aquino, Samuel I. Cockriel, Serah R. Friedman, Bita Kianian, Yinan Lin, Eric R. Malmgren, Brian M.Z. Reece, Derk A.
Westermeyer, Suyoung Jang, Show Xiaoyu Wang, Justin E. Culbertson, Andrew E. Morrell, Victoria E. Ellis, Yasmin L. Amin-Reimer, Jeremiah S. Helm, Hironori Kubota, Paul C. Steinhardt, Kregg A. Koch,
Andrew D. Lee, and Yusuke Hirai of Knobbe, Martens, Olson & Bear, LLP 2040 Main Street, 14th Floor
Irvine, California 92614
United States
949-760-0404(phone)
949-760-9502(fax)
efiling@knobbe.com (authorized)
The attorney docket/reference number is EBLM057.001T.
The applicant hereby appoints Stacey Halpern of Knobbe, Martens, Olson & Bear, LLP
2040 Main Street, 14th Floor
Irvine California 92614
United States
949-760-0404(phone)
949-760-9502(fax)
efiling@knobbe.com (authorized)
as applicant's representative upon whom notice or process in the proceedings affecting the mark may be served.
The applicant's current Correspondence Information:
Stacey Halpern
Knobbe, Martens, Olson & Bear, LLP
2040 Main Street, 14th Floor
Irvine, California 92614
949-760-0404(phone)
949-760-9502(fax)
efiling@knobbe.com (authorized) E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at
the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent
application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional
processing fee of $125 per international class of goods/services.
A fee payment in the amount of $1375 has been submitted with the application, representing payment for 5 class(es).
Declaration
Declaration Signature
Signature: Not Provided Date: Not Provided
Signatory's Name: Not Provided
Signatory's Position: Not Provided
Payment Sale Number: 88468906
Payment Accounting Date: 06/12/2019
Serial Number: 88468906
Internet Transmission Date: Tue Jun 11 18:54:13 EDT 2019
TEAS Stamp: USPTO/BAS-XXX.XXX.XX.XX-2019061118541355
0699-88468906-62067f8a78920e9586e488ea72
9d872e961bf0dc69546bbca62faf8a791964c96-
CC-5829-20190611183319448875